Group 1 - The company, Limin Co., Ltd. (002734.SZ), reported that its current production and operational status is normal [2] - The pesticide industry is transitioning from off-peak to peak season, with demand gradually recovering [2] - The company anticipates that pesticide prices will stabilize and rebound in the near future [2]

Group 1 - The company's main products, Mancozeb and Chlorothalonil, have a production capacity of 45,000 tons/year and 30,000 tons/year respectively, both operating at full production and sales capacity [2] - The company holds a 34% stake in Xinhe Company, which produces Chlorothalonil [2] Group 2 - The company is actively engaging with investors through an interactive platform to provide updates on production capacity and utilization rates [2] - The current production utilization rate for both products is at maximum capacity, indicating strong demand and operational efficiency [2]

特别提示： 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 | 股票代码：002734 | 股票简称：利民股份 | 公告编号：2025-094 | | --- | --- | --- | | 债券代码：128144 | 债券简称：利民转债 | | 利民控股集团股份有限公司 关于利民转债预计触发赎回条件的提示性公告 自 2025 年 11 月 14 日至 2025 年 11 月 26 日，利民控股集团股份有限公司（以 下简称"公司"）股票已有 9 个交易日的收盘价不低于 "利民转债"当期转股价格 （即 8.10 元/股）的 130%（即 10.53 元/股），预计后续可能触发"利民转债"有 条件赎回条款。根据《公司公开发行可转换公司债券募集说明书》（以下简称《募 集说明书》）中有条件赎回条款的相关规定，届时公司董事会有权决定是否按照债 券面值加当期应计利息的价格赎回全部或部分未转股的"利民转债"。敬请广大投 资者详细了解可转换公司债券相关规定，并及时关注公司后续公告，注意投资风险。 一、可转换公司债券上市发行概况 （一）可转债发行情况 经中国证券监督管理委员会《 ...

Investment Rating - The report maintains a "Recommended" rating for the chemical industry [1] Core Views - The chemical industry is expected to benefit from the ongoing "anti-involution" measures, which may lead to a significant slowdown in global chemical capacity expansion. This shift is anticipated to enhance cash flow and dividend yields for companies in the sector, transforming them from cash-consuming entities to cash-generating ones [7][27] - The report highlights the potential for domestic substitutes for Japanese semiconductor materials due to rising tensions in Sino-Japanese relations, which could accelerate the domestic market's growth in this area [6] Summary by Sections Recent Trends - The chemical industry has shown a relative performance increase of 16.1% over the past 12 months, outperforming the CSI 300 index, which increased by 11.6% [4] Key Price Movements - DMC (Dimethyl Carbonate) prices rose to 4400 CNY/ton, up 14.29% week-on-week, driven by strong demand from the electrolyte sector [14] - Lithium battery electrolyte prices increased to 27000 CNY/ton, up 8.00% week-on-week, although profit margins for manufacturers are under pressure due to rising raw material costs [14] - Diammonium phosphate prices in East China reached 3850 CNY/ton, up 5.48% week-on-week, amid rising production costs [14] Investment Opportunities - The report identifies four key opportunities in the chemical sector: 1. Low-cost expansion, focusing on companies like Wanhua Chemical and Hualu Hengsheng [9] 2. Improved industry conditions, particularly in chromium salts and phosphate rock [10] 3. New materials with high growth potential, such as electronic chemicals and aerospace materials [11] 4. High dividend yields from state-owned enterprises in the chemical sector, including China Petroleum and China National Chemical [11] Company Tracking and Earnings Forecast - The report provides a detailed earnings forecast for key companies, indicating a positive outlook for several firms in the chemical sector, with many rated as "Buy" [28]

Group 1 - The core point of the news is that Limin Co., Ltd. experienced a decline in stock price and trading volume on November 20, with a drop of 3.89% and a transaction amount of 431 million yuan [1] - On November 20, Limin Co., Ltd. had a financing buy-in amount of 44.83 million yuan and a financing repayment of 64.24 million yuan, resulting in a net financing buy of -19.41 million yuan [1] - As of November 20, the total balance of margin trading for Limin Co., Ltd. was 470 million yuan, accounting for 5.95% of its circulating market value [1] Group 2 - As of November 10, the number of shareholders of Limin Co., Ltd. was 61,000, a decrease of 2.35% from the previous period, while the average circulating shares per person increased by 2.41% to 6,599 shares [2] - For the period from January to September 2025, Limin Co., Ltd. achieved an operating income of 3.599 billion yuan, representing a year-on-year growth of 7.62%, and a net profit attributable to the parent company of 390 million yuan, a significant increase of 661.66% [2] - Since its A-share listing, Limin Co., Ltd. has distributed a total of 919 million yuan in dividends, with 321 million yuan distributed in the last three years [2]

Core Points - Pingtan Development and Haixia Innovation have completed their suspension review and will resume trading on November 21, 2025 [1][2] - Eddy Precision and Hangcai Co. plan to repurchase shares [3] - Wenfeng Co.'s deputy general manager has been placed under investigation [4] - Kesi Co. has undergone a change in its actual controller [6][7] - Major events include the completion of restructuring investments by *ST Lian Shi and acquisitions by Jun Ting Hotel and Lek Electric [8][9] Group 1: Resumption of Trading - Pingtan Development's stock will resume trading on November 21, 2025, after confirming no significant changes in its operations or undisclosed major matters [1] - Haixia Innovation's stock will also resume trading on November 21, 2025, with similar confirmations regarding its operational status [2] Group 2: Share Repurchase Plans - Eddy Precision plans to repurchase shares with a total amount between 100 million and 200 million yuan, at a price not exceeding 27 yuan per share [3] - Hangcai Co. intends to repurchase shares using excess funds, with a total amount between 50 million and 100 million yuan, at a price not exceeding 80 yuan per share [3] Group 3: Investigations and Changes in Management - Wenfeng Co.'s deputy general manager, Qin Guofen, is under investigation, but the company states this will not significantly impact its operations [4] - Kesi Co. has changed its actual controller from Zhou Jiuqing and Zhou Xuming to Zhou Xuming alone following the death of Zhou Jiuqing [6][7] Group 4: Major Events - *ST Lian Shi has received a total of 1.238 billion yuan in restructuring investments from all investors [8] - Jun Ting Hotel has agreed to acquire the remaining 21% stake in Junlan Management for 79.8 million yuan, making it a wholly-owned subsidiary [9] - Lek Electric plans to transfer 90% of its subsidiary's equity to Chuangyuan Resources, with a target valuation of 235 million yuan [9]

Group 1 - The core point of the article is that Limin Co., Ltd. announced the approval of its environmental impact report for a new project aimed at producing 100 tons of a new type of efficient multifunctional pesticide raw material [2] Group 2 - The approval was issued by the Jiangsu Provincial Department of Ecology and Environment, indicating regulatory compliance for the company's technological upgrade project [2]

Group 1 - EVE Energy signed a procurement framework agreement with its affiliate, Smoore International, for continuous procurement of battery cells starting from January 1, 2026 [1] - Zhaoyi Information plans to issue H-shares and list on the Hong Kong Stock Exchange [1] - Fuke Environmental announced a change in its stock abbreviation to "Fuke Technology" effective November 26 [1] Group 2 - Dajia Weikang's shareholder and director terminated a share reduction plan ahead of schedule, having reduced 1% of total shares [2] - Aohong Electronics received approval from the China Securities Regulatory Commission for the issuance of convertible bonds [2] - Yingfeng Environment's controlling shareholder plans to issue exchangeable bonds not exceeding 1 billion yuan [2] Group 3 - Longshen Rongfa's subsidiary obtained a renewed drug production license covering various pharmaceutical products [4] - Xinhua News' subsidiary invested 15 million yuan in a fund with a total commitment of 221 million yuan [5] - Guang'an Aizhong appointed two new deputy general managers [6] Group 4 - Fosun Pharma's subsidiary's drug for gastric cancer treatment was included in the breakthrough therapy program by the National Medical Products Administration [7] - Nanjiao Foods reported a significant decline in October net profit due to rising raw material costs [8] - Nanfeng Co. won two nuclear power project bids totaling 928.7 million yuan [10] Group 5 - Puluo Pharmaceutical received a drug registration certificate for its Cefdinir capsules [11] - Liming Co.'s subsidiary received environmental approval for a new pesticide raw material project [12] - Longhua New Materials' expansion project for polyether polyols has commenced trial production [13] Group 6 - Pumen Technology's products received IVDR CE certification from TÜV Rheinland [15] - China Chemical reported new contracts worth 312.67 billion yuan from January to October [18] - China Nuclear Construction achieved new contracts totaling 123.84 billion yuan as of October [19] Group 7 - Changshu Bank's executives plan to purchase at least 550,000 shares of the bank [20] - Shandong Steel's subsidiary is applying for bankruptcy liquidation to focus on core business [21] - Huakang Clean is expected to win a bid for a purification system project worth 176 million yuan [23] Group 8 - Huawu Co. plans to internally transfer subsidiary equity [24] - Tianen Kang's subsidiary received clinical trial acceptance for a new drug [26] - Tianyi Medical's subsidiary obtained a medical device registration certificate for a blood dialysis product [27] Group 9 - Xuelang Environment is facing a pre-restructuring application from creditors [27] - Chitianhua's subsidiary resumed production after passing safety inspections [28] - Huaping Co.'s director plans to reduce 0.03% of company shares [30] Group 10 - Xizhuang Co. plans to establish a wholly-owned subsidiary in Singapore [31] - Ruisheng Intelligent's subsidiary won a 60.23 million yuan ICT project bid [32] - Junyi Digital plans to invest 120 million yuan in Guanghong Precision [33] Group 11 - Fuguang Co.'s controlling shareholder plans to increase holdings between 80 million to 150 million yuan [34] - Ganyue Express reported a 13.68% increase in logistics revenue in October [39] - Jiangsu Sop terminated its 2025 private placement plan [41] Group 12 - Langke Intelligent's shareholders plan to reduce a total of 1.68% of company shares [42] - Yuantong Express reported an 8.97% increase in express product revenue in October [45] - Jinbei Automotive plans to invest 158 million yuan to acquire 52% of Zhongtuo Technology [46]

Core Viewpoint - The company has received approval for an environmental impact report regarding its new project, which will enhance its production capacity for a specific agricultural chemical [1] Group 1: Project Approval - The company’s wholly-owned subsidiary, Limin Chemical Co., Ltd., has received approval from the Jiangsu Provincial Department of Ecology and Environment for its project [1] - The project involves the construction of a new high-efficiency multifunctional pesticide active ingredient production facility with an annual capacity of 100 tons of fluopyram [1] Group 2: Environmental Compliance - The approval includes requirements for the company to ensure that pollutants are discharged within regulatory limits [1] - The company is mandated to implement the "three simultaneous" system, which requires that environmental protection facilities be designed, constructed, and put into operation concurrently with the main project [1]

Core Viewpoint - Limin Co., Ltd. has received approval from the Jiangsu Provincial Department of Ecology and Environment for its subsidiary Limin Chemical's project to produce 100 tons of a new type of efficient multifunctional pesticide raw material annually [1] Group 1: Project Approval - The approval allows Limin Chemical to construct a new efficient multifunctional pesticide raw material project within its existing plant [1] - The project will have an annual production capacity of 100 tons of fluopyram raw material [1] Group 2: Environmental Compliance - The company is required to implement all environmental protection measures outlined in the approval to ensure pollutant emissions meet standards [1] - The project must adhere to the "three simultaneous" system, which mandates that environmental protection facilities are designed, constructed, and put into operation concurrently with the main project [1]